Supplier News Breaks Archives
The Food and Drug Administration has approved generic versions of Plavix (clopidogrel bisulfate), a blood-thinning drug, from nine pharmaceutical manufacturers.
Frito-Lay North America has begun a multiyear initiative to validate many of its snack products as gluten-free, with package labeling to follow.
Adam Kmiec has been appointed director of digital marketing and social media at Campbell Soup Co.
This month Coty Inc. is rolling out Nautica Aqua Rush, targeted at the "adventurous" man.
Pernix Therapeutics Holdings Inc. has introduced the Omeclamox-Pak, the first product in its gastroenterology portfolio.
CutisPharma Inc. recently presented studies that attest to the reliability of its Magic Mouthwash prescription compounding kits.
David Fishman has joined Majestic Drug Co. as vice president.
Amneal Pharmaceuticals has made formulation and labeling changes to its generic metformin products that provide key improvements for pharmacists and patients.
Abbott has launched PediaSure SideKicks Clear, a children's nutritional beverage designed to supplement the diet of picky eaters who are growing fine but may be missing nutrients.
Next month, AstraZeneca will have new faces in the posts of chief executive officer and chairman.
Ermis Labs has landed distribution of its CoralActives acne treatment line with Kinney Drugs.
Coty Inc. has withdrawn its $10.7 billion proposed acquisition of beauty care supplier Avon Products Inc.
Kellogg Co. is unveiling a refresh of its 106-year-old Kellogg's brand, calling the move the most significant update of its marquee identity in company history.
QS/1 has released RetrieveRx, a will-call storage and retrieval system aimed at helping pharmacies eliminate the clutter and guesswork of storing and locating filled prescriptions.
Red Carpet Manicure, maker of an innovative at-home gel nail manicure system, has introduced new limited-edition special shade effects for the summer.
Janick Boudazin has been promoted to president and chief executive officer of Boiron Inc.
Stiefel has received approval from the Food and Drug Administration for Fabior Foam (tazarotene 0.1%), an acne treatment.